Keyphrases
Tyrosine Kinase Inhibitor
100%
Cell Survival
100%
Metabolic Reprogramming
100%
K562 Cells
100%
Multi-omics Profiling
100%
Inhibitor Resistant
100%
Tyrosine Kinase Inhibitor Resistance
60%
Resistance Mechanisms
40%
Proteomics
20%
Genome Analysis
20%
Quantitative Measurement
20%
Alpha-synuclein (α-syn)
20%
Metabolism
20%
Mitochondrial Metabolism
20%
Proteomic Analysis
20%
Metabolic Profiling
20%
Chronic Myeloid Leukemia
20%
Oxidative Stress Response
20%
Transcriptomic Profiling
20%
Protein Expression Level
20%
Metabolic Pathway
20%
Leukemia Therapy
20%
Transcriptome Analysis
20%
Established Cell Lines
20%
Resistant Cells
20%
Protein Alteration
20%
Kinase Inhibition
20%
Glycolysis
20%
Isotopic Labeling
20%
Gene Expression Level
20%
Resistance Model
20%
Pentose Phosphate Pathway
20%
Kinase mutation
20%
Proteomic Profiling
20%
Hypoxia Signature
20%
Whole Transcriptome Sequencing
20%
Resistance to Chemotherapy
20%
Gene Expression Alterations
20%
Integrated Understanding
20%
Line Resistance
20%
Non-target-site Resistance
20%
Data-independent Acquisition Mass Spectrometry (DIA-MS)
20%
Glucose Dependence
20%
Tyrosine Kinase Inhibitor Treatment
20%
Immunology and Microbiology
Cell Line
100%
Cell Survival
100%
Transcriptomics
100%
RNA Sequencing
50%
Metabolism
50%
Gene Expression
50%
Myeloid
50%
Mitochondrial Respiration
50%
Pentose Phosphate Cycle
50%
Protein Expression Level
50%
Gene Expression Level
50%
Hexose Monophosphate Shunt
50%
Metabolite
50%
Oxidative Stress
50%
Biochemistry, Genetics and Molecular Biology
Tyrosine Kinase Inhibitor
100%
Cell Survival
100%
Reprogramming
100%
K562 Cells
100%
Proteomics
33%
Metabolic Pathway
22%
Transcriptomics
22%
Phosphotransferase
22%
Kinase
22%
Quantitative Technique
11%
Metabolite
11%
RNA Sequencing
11%
Protein Expression Level
11%
Gene Expression
11%
Oxidative Stress
11%
Mitochondrial Respiration
11%
Mass Spectrometry
11%
Myeloid
11%
Gene Expression Level
11%
Hexose Monophosphate Shunt
11%
Alpha-Synuclein
11%